A zebrafish seizure model of cblX syndrome reveals a dose-dependent refractory response to mTor inhibition.
Claudia B. Gil, David Paz, Briana E. Pinales…·Anita M. Quintana
This study uses a zebrafish model of cblX syndrome to show that mTor inhibition at moderate doses reduces seizure severity, but higher doses cause a refractory response in hcfc1a mutants.